ESR1 and endometrial cancer: Contrary to this, a higher mRNA expression of ESR1 in HOSC could be attributed to a ligand-independent action of ESR1 as previous studies in human endometrial cancer cells, have reported higher estrogen-independent activity of ESR1 in D538G mutants compare to their wild-type counterparts [42].